1I6V image
Deposition Date 2001-03-05
Release Date 2001-04-18
Last Version Date 2024-10-30
Entry Detail
PDB ID:
1I6V
Keywords:
Title:
THERMUS AQUATICUS CORE RNA POLYMERASE-RIFAMPICIN COMPLEX
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
3.30 Å
R-Value Free:
0.35
R-Value Work:
0.27
R-Value Observed:
0.28
Space Group:
P 41 21 2
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:DNA-DIRECTED RNA POLYMERASE
Gene (Uniprot):rpoA
Chain IDs:A, B
Chain Length:314
Number of Molecules:2
Biological Source:Thermus aquaticus
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:DNA-DIRECTED RNA POLYMERASE
Gene (Uniprot):rpoB
Chain IDs:C
Chain Length:1118
Number of Molecules:1
Biological Source:Thermus aquaticus
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:DNA-DIRECTED RNA POLYMERASE
Gene (Uniprot):rpoC
Chain IDs:D
Chain Length:1264
Number of Molecules:1
Biological Source:Thermus aquaticus
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:DNA-DIRECTED RNA POLYMERASE
Gene (Uniprot):rpoZ
Chain IDs:E
Chain Length:99
Number of Molecules:1
Biological Source:Thermus aquaticus
Primary Citation
Structural mechanism for rifampicin inhibition of bacterial rna polymerase.
Cell(Cambridge,Mass.) 104 901 912 (2001)
PMID: 11290327 DOI: 10.1016/S0092-8674(01)00286-0

Abstact

Rifampicin (Rif) is one of the most potent and broad spectrum antibiotics against bacterial pathogens and is a key component of anti-tuberculosis therapy, stemming from its inhibition of the bacterial RNA polymerase (RNAP). We determined the crystal structure of Thermus aquaticus core RNAP complexed with Rif. The inhibitor binds in a pocket of the RNAP beta subunit deep within the DNA/RNA channel, but more than 12 A away from the active site. The structure, combined with biochemical results, explains the effects of Rif on RNAP function and indicates that the inhibitor acts by directly blocking the path of the elongating RNA when the transcript becomes 2 to 3 nt in length.

Legend

Protein

Chemical

Disease

Primary Citation of related structures